Smart shoes could ease walking pain for millions
NCT ID NCT04337554
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested special exoskeleton footwear designed to assist walking in people aged 40 and older with peripheral artery disease (PAD). Researchers compared different levels of assistance to see which worked best for comfort and walking performance. The study included 47 participants and measured how the shoes affected walking mechanics, muscle oxygen, and energy use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Exoskeleton footwear (assistive device)
- What this could lead to
- If successful, this device could help people with peripheral artery disease walk more easily and with less discomfort.
- What could go wrong
- This is a small, early-stage study focused on finding the best assistance level, not proving long-term benefits. The device may not work for everyone or be practical for daily use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska, 68105-1850, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Beetroot juice may boost heart blood flow and walking in leg artery disease
- Can a Pre-Surgery skin coating stop wound infections?
- Can a 'Scoring' balloon unclog leg arteries better and reduce stents?
- Can a temporary stent keep leg arteries open?
- Can a Lab-Grown artery graft outlast current options?
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test